Hamid Saeed
Overview
Explore the profile of Hamid Saeed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azhar M, Alasmari M, Zamir A, Saeed H, Alqahtani F, Ahmad T, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861183
Glimepiride (GLM), a commonly used sulphonylurea drug for the management of type 2 diabetes mellitus (T2DM), has been the subject of numerous studies exploring its kinetic behaviors. However, a comprehensive...
2.
Batool M, Zamir A, Alqahtani F, Ahmad T, Saeed H, Rasool M
Pharmaceutics
. 2025 Jan;
16(12.
PMID: 39771597
Fexofenadine hydrochloride is a widely prescribed drug for treating histamine-mediated allergic reactions. This review systematically collates existing research on the clinical pharmacokinetics (PK) of fexofenadine, with a copious emphasis on...
3.
Saleem Naz Babari I, Islam M, Saeed H, Nadeem H, Rathore H
Saudi Pharm J
. 2024 Nov;
32(11):102191.
PMID: 39507051
Oxazoles and Imidazoles are heterocyclic compounds with significant biological activities. The present study explores the pharmacological effects of some new oxazole and imidazole derivatives as potential COX-2 inhibitors. Docking studies...
4.
Alam K, Khan A, Fatima A, Haseeb A, Jaffar D, Mussarat A, et al.
Clin Neurol Neurosurg
. 2024 Sep;
246:108523.
PMID: 39278007
Background: Intravenous thrombolysis (IVT) is considered a standard reperfusion therapy for acute ischemic stroke (AIS) patients presenting within 4.5 hours of the last known well (LKW). Current guidelines contraindicate the...
5.
Fayyaz S, Islam M, Ahmed A, Saeed H
Cell Biochem Funct
. 2024 Sep;
42(7):e4124.
PMID: 39275928
Obesity and hyperlipidemia have become major disorders predominantly causing prevailing cardiovascular diseases and ultimately death. The prolonged use of anti-obesity drugs and statins for reducing obesity and blood lipid levels...
6.
Khan H, Zamir A, Imran I, Saeed H, Alqahtani F, Majeed A, et al.
Expert Opin Drug Metab Toxicol
. 2024 Sep;
21(1):69-79.
PMID: 39267225
Introduction: Glipizide is an oral antidiabetic drug widely used to treat non-insulin-dependent type II diabetes mellitus (NIDDM). This systematic review extensively examines all reported pharmacokinetic (PK) parameters of glipizide in...
7.
Ayub A, Zamir A, Imran I, Saeed H, Majeed A, Aziz M, et al.
Expert Opin Drug Metab Toxicol
. 2024 Sep;
20(11-12):1053-1067.
PMID: 39252195
Introduction: Nicardipine is a type of calcium channel blocker that is commonly used in the treatment of angina pectoris, hypertension, and related cardiovascular disorders. This systematic review assesses the reported...
8.
Farooq A, Zamir A, Imran I, Saeed H, Alqahtani F, Ur Rehman A, et al.
Expert Opin Drug Metab Toxicol
. 2024 Aug;
20(10):989-1001.
PMID: 39120118
Introduction: Cefpodoxime, a third-generation cephalosporin, is a broad-spectrum antibiotic widely used to treat acute upper respiratory tract infections (RTI). This systematic review aims to present a comprehensive view of all...
9.
Pasha M, Zamir A, Rasool M, Saeed H, Ahmad T, Alqahtani N, et al.
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065773
Physiologically based pharmacokinetic (PBPK) modeling is of great importance in the field of medicine. This study aims to construct a PBPK model, which can provide reliable drug pharmacokinetic (PK) predictions...
10.
Rasool M, Sarwar R, Arshad M, Imran I, Saeed H, Majeed A, et al.
Risk Manag Healthc Policy
. 2024 Apr;
17:775-776.
PMID: 38595752
No abstract available.